Free Trial

Rafferty Asset Management LLC Has $404,000 Stock Position in Celcuity Inc. (NASDAQ:CELC)

Celcuity logo with Medical background

Rafferty Asset Management LLC lowered its holdings in shares of Celcuity Inc. (NASDAQ:CELC - Free Report) by 45.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30,878 shares of the company's stock after selling 25,709 shares during the period. Rafferty Asset Management LLC owned about 0.08% of Celcuity worth $404,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the business. Nuveen Asset Management LLC boosted its stake in Celcuity by 10.8% during the fourth quarter. Nuveen Asset Management LLC now owns 69,587 shares of the company's stock worth $911,000 after buying an additional 6,785 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Celcuity by 16.2% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,725 shares of the company's stock worth $258,000 after buying an additional 2,756 shares in the last quarter. J. Goldman & Co LP acquired a new stake in Celcuity during the fourth quarter worth $567,000. Janus Henderson Group PLC acquired a new stake in Celcuity during the fourth quarter worth $8,468,000. Finally, Deutsche Bank AG boosted its stake in Celcuity by 67.1% during the fourth quarter. Deutsche Bank AG now owns 22,842 shares of the company's stock worth $299,000 after buying an additional 9,174 shares in the last quarter. Institutional investors and hedge funds own 63.33% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the stock. Needham & Company LLC reiterated a "buy" rating and set a $29.00 price target on shares of Celcuity in a research note on Thursday, May 15th. HC Wainwright reiterated a "buy" rating and set a $27.00 price target on shares of Celcuity in a research note on Monday, May 19th. Five equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Buy" and a consensus target price of $30.80.

View Our Latest Report on CELC

Celcuity Price Performance

Shares of NASDAQ:CELC traded up $0.29 on Thursday, hitting $10.79. The stock had a trading volume of 12,669 shares, compared to its average volume of 297,553. Celcuity Inc. has a twelve month low of $7.58 and a twelve month high of $19.77. The company has a debt-to-equity ratio of 0.65, a quick ratio of 10.36 and a current ratio of 10.35. The firm's 50 day moving average price is $10.19 and its 200-day moving average price is $11.42. The company has a market capitalization of $408.38 million, a price-to-earnings ratio of -4.13 and a beta of 0.56.

Celcuity (NASDAQ:CELC - Get Free Report) last issued its earnings results on Wednesday, May 14th. The company reported ($0.86) EPS for the quarter, beating the consensus estimate of ($0.95) by $0.09. On average, equities research analysts predict that Celcuity Inc. will post -2.62 earnings per share for the current year.

Celcuity Company Profile

(Free Report)

Celcuity Inc, a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment.

See Also

Institutional Ownership by Quarter for Celcuity (NASDAQ:CELC)

Should You Invest $1,000 in Celcuity Right Now?

Before you consider Celcuity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celcuity wasn't on the list.

While Celcuity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines